New Alzheimer's Drug May Help Mildly Impaired

Wednesday, 16 Jul 2014 12:34 PM

 

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink

Researchers say an experimental drug from the biotech company Genentech failed to slow mental decline in tests on more than 500 people with mild to moderate Alzheimer's disease.
The drug did show some promise in the least-impaired participants who received the higher of two doses in the mid-stage studies.

The drug, crenezumab (cruh-NEZ-oo-mab), aims to clear away the sticky amyloid plaques clogging Alzheimer's patients' brains.

The company says it is encouraged by the possible benefit for mildly impaired patients and will talk with regulators about the next steps to test the drug.

Results were discussed Wednesday at the Alzheimer's Association International Conference in Copenhagen.
 

© Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Food Pesticide Residue Nothing to Worry About: USDA

Saturday, 20 Dec 2014 10:26 AM

More than half of food tested by the U.S. government for pesticide residues last year showed detectable levels of pestic . . .

Beware of Holiday Allergy Triggers

Saturday, 20 Dec 2014 10:16 AM

The holidays can be anything but joyous for people with allergies when they contend with fresh trees, scented candles an . . .

Diagnose Your Kid's Ear Infection With Your iPhone

Friday, 19 Dec 2014 16:15 PM

Diagnosing your kid's ear infections might soon be as simple as taking a video on your smartphone. . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved